← All stocks

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC Net buying
CIK 0001500198 #5044 in the set updated 17 Sep 2026
Bought (1 mo)
$67.00K
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$67.00K
+$67.00K against sales at will

By person

9 insiders · 1 transaction
4.0×

Dave Rosa holds only 4.0 times base salary in stock. $2.17M of shares against $535.43K in salary for 2025.

Salary from the company's own proxy. The shares are what Dave Rosa last reported holding, valued at $2.01, the price Common Stock was last bought or sold at on the open market here, on 27 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Wambeke David J.
Chief Business Officer
$67.00K (1)
+$67.00K
199,999
$402.00K
Rosa David A
CEO & President
1,080,132
$2.17M
−5.8%
McClurg Ronald W.
Chief Financial Officer
444,117
$892.68K
+81.9%
BUCKMAN PAUL
Director
178,733
$359.25K
+63.9%
MATHIESEN JEFFREY S
Director
156,343
$314.25K
+80.5%
Mertens Steve
Chief Technology Officer
152,141
$305.80K
−12.8%
Andrle Edward
Director
133,932
$269.20K
+108.5%
Mills Jason Richard
Director
49,687
$99.87K
Christianson Mark
Market Development Director
20,692
$41.59K
−83.6%

No percentages here. This company's share count has moved by a factor of 5.8 over the window, from 8,619,876 to 50,413,148 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 14 Jul 2017